Trial Profile
A Phase I Study of UCN-01 in Combination With Topotecan in Patients With Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jul 2016
Price :
$35
*
At a glance
- Drugs Topotecan (Primary) ; UCN 01 (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer; Solid tumours
- Focus Adverse reactions
- 06 Jul 2016 New trial record